BWX Technologies, Inc. Profile Avatar - Palmy Investing

BWX Technologies, Inc.

BWX Technologies, Inc. manufactures and sells nuclear components in the United States, Canada, and internationally. It operates in three segments: Nuclear Operations Group, Nuclear Power Group, and Nuclear Services Group.

Aerospace & Defense
US, Lynchburg [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 50% Balanced
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 43.77 88.69 61.69
Graham Fair Price 2.79 13.19 12.83
PEG 178.43 8.18 2.94
Price/Book 30.81 9.86 7.54
Price/Cash Flow 8607.25 3582.75 41.15
Prices/Earnings 27.61 34.07 26.69
Price/Sales 59.30 15.45 9.70
Price/FCF 8607.25 3582.75 41.15
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -5.34 0.25 0.26
Operating Margin -0.59 0.15 0.15
ROA 2.39 0.02 0.02
ROE 0.07 0.07 2.50
ROIC 0.04 0.03 -18.20
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ < 0.005 -0.08 98.74
Dividends QOQ < 0.005 0.06 3451.10
EBIT QOQ 0.32 -0.17 -45.43
EPS QOQ 0.09 0.04 -54.17
FCF QOQ 2.94 -0.98 -66.47
Revenue QOQ 0.23 -0.17 -27.07
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 4.59 8.18 78.16
Days Sales Outstanding (DSO) 83.72 108.70 29.84
Inventory Turnover 19.60 11.00 -43.87
Debt/Capitalization 0.57 0.56 -0.06
Quick Ratio 2.01 2.00 -0.23
Naive Interpretation member
04 - Leverage & Liquidity · Balanced
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 10.18 10.33 1.52
Cash 0.86 0.50 -41.54
Capex -0.55 -0.33 40.01
Free Cash Flow 1.86 0.03 -98.47
Revenue 7.91 6.60 -16.63
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.18 2.24 2.51
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 8.68 9.98 15.02
Naive Interpretation Member
06 - Financial Health · Bad
End of BWXT's Analysis
CIK: 1486957 CUSIP: 05605H100 ISIN: US05605H1005 LEI: - UEI: -
Secondary Listings
BWXT has no secondary listings inside our databases.